UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)


X    QUARTERLY  REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT
     OF 1934

     For quarterly period ended March 31, 2002

     TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR  15(d)  OF THE  SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from _____ to _______

Commission file number:  0-28790

                          ENTERPRISE TECHNOLOGIES, INC.
                           --------------------------
             (exact name of registrant as specified in its charter)

           NEVADA                                        87-0429962 B
           ------                                       ---------------
(State or other jurisdiction of                (IRS Employer Identification No.)
incorporation or organization)

Suite 216 - 1628 West 1st Avenue, Vancouver, BC,              V6J 1G1
------------------------------------------------              -------
(Address of principal executive offices)                     (zip code)

Registrant's telephone number, including area code:           (604) 659-5018
                                                            ------------------

Indicate  by check  mark  whether  the  registrant:  (1) has filed  all  reports
required by Section 13 or 15 (d) of the  Securities  Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No ----

The number of shares of the Registrant's Common Stock, $0.00001 par value, as of
April 30, 2002: 123,466,166.

<PAGE>

                          ENTERPRISE TECHNOLOGIES, INC.
                    FORM 10-QSB, QUARTER ENDED MARCH 31, 2002

<TABLE>
INDEX
<CAPTION>


PART I    FINANCIAL INFORMATION

Item 1.    Financial Statements
<S>                                                                            <C>
Consolidated Balance Sheet...................................................  3
Consolidated Statement of Operations.........................................  4
Consolidated Statement of Cash Flows.........................................  5
Notes to Interim Financial Statements........................................  7
Item 2.  Management's Discussion and Analysis................................  9

PART II   OTHER INFORMATION

Item 1. Legal Proceedings....................................................  12
Item 2. Changes in Securities................................................  12
Item 3. Defaults Upon Senior Securities......................................  12
Item 4. Submission of Matters to a Vote of Security Holders..................  12
Item 5. Other Information....................................................  12
Item 6. Exhibits and Reports on Form 8-K.....................................  12
Signatures...................................................................  13

</TABLE>

Item 1.   Financial Statements

                 ENTERPRISE TECHNOLOGIES, INC. AND SUBSIDIARIES
                       INTERIM CONSOLIDATED BALANCE SHEET
                                 MARCH 31, 2002
                                   (Unaudited)
<TABLE>
<CAPTION>
ASSETS

<S>                                                                             <C>
Current Assets
   Cash                                                                         $       7,824

Total Assets                                                                    $       7,824

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
   Accounts payable and accrued liabilities                                     $     295,072
   Loans from shareholder                                                              10,200
Total Current Liabilities                                                             305,272

Stockholders' Equity
   Preferred stock:  $0.25 par value; Authorized shares 1,000,000;
        Issued and outstanding, none
                                                                                            0
  Common stock: $0.00001 par value; Authorized shares
        300,000,000; Issued and outstanding, 123,466,166                                1,235
   Warrants                                                                           117,830
   Additional paid in capital                                                      13,526,002
   Accumulated deficit                                                            (13,942,515)
Total Stockholders' Equity                                                           (297,448)

Total Liabilities and Stockholders' Equity                                      $       7,824

</TABLE>


                  See notes to condensed financial statements.

<PAGE>

                 ENTERPRISE TECHNOLOGIES, INC. AND SUBSIDIARIES
                  INTERIM CONSOLIDATED STATEMENT OF OPERATIONS
               FOR THE THREE MONTHS ENDED MARCH 31, 2002 AND 2001
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                    For the Three          For the Three
                                                                    Months Ended           Months Ended
                                                                    March 31, 2002         March 31, 2001
                                                                    --------------         --------------
<S>                                                                 <C>                    <C>
Revenues                                                            $           0          $       24,560

General and administrative                                                 44,403                 284,978

Operating Loss                                                      $     (44,403)         $     (260,418)

Other Income
   Interest income                                                             13                   1,115

Net loss                                                            $     (44,390)         $     (259,303)

Less: preferred stock deemed dividends                                          0                 (13,866)

Net loss available to common shareholders                           $     (44,390)         $     (273,169)

Basic and diluted loss per common share                             $     (0.0003)         $        (0.02)


Weighted average common shares outstanding:
Basic and diluted                                                     123,466,166              13,364,566

</TABLE>

                  See Notes to condensed financial statements.

<PAGE>

                 ENTERPRISE TECHNOLOGIES, INC. AND SUBSIDIARIES
                  INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
               FOR THE THREE MONTHS ENDED MARCH 31, 2002 AND 2001
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                Three Months Ended   Three Months Ended
                                                                                March 31,            March 31,
                                                                                2002                 2001
                                                                                ----                 ----
<S>                                                                             <C>                  <C>
Cash flows from operating activities
   Net loss                                                                     $       (44,390)     $      (259,303)
   Adjustments to reconcile net loss to net cash used
   in operating activities
   Changes in assets and liabilities
      (Increase) decrease in accounts receivable                                              0               17,343
      (Increase) decrease in stock subscription receivable                                    0              101,329
       Increase (decrease) in accounts payable                                           35,254               14,163
                                                                                ------------------------------------
   Total adjustments                                                                     35,254              132,835
                                                                                ------------------------------------
Net cash flows used in operating activities                                             (9,136)             (126,468)

Cash flows from investing activities                                                          0                    0

Cash flows from financing activities
   Proceed from sales of common stock                                                         0              188,671
   Loans from shareholder                                                                10,200                    0
                                                                                ------------------------------------
Net cash flows provided by financing activities                                          10,200              188,671
                                                                                ------------------------------------
Increase in cash and cash equivalents                                                     1,064               62,203
Cash and cash equivalents, beginning of period                                            6,760               34,856
                                                                                ------------------------------------
Cash and cash equivalents, end of period                                        $         7,824      $        97,059


Cash paid for interest and income taxes                                         $             0      $             0
Preferred stock deemed dividends                                                $             0      $        13,866

</TABLE>

                 See notes to condensed to financial statements.

<PAGE>

                 ENTERPRISE TECHNOLOGIES, INC. AND SUBSIDIARIES
                      NOTES TO INTERIM FINANCIAL STATEMENTS
                                 MARCH 31, 2002

Note 1 - Presentation of Interim Information

The accompanying  unaudited interim  financial  statements have been prepared in
accordance  with Form 10-QSB  instructions  and in the opinion of  management of
Enterprise Technologies, Inc. and Subsidiaries (the Company), include all normal
adjustments  considered necessary to present fairly the financial position as of
March 31, 2002 and the results of operations and cash flows for the three months
ended March 31, 2002 and 2001.  These results have been  determined on the basis
of  generally   accepted   accounting   principles  and  practices  and  applied
consistently  with those used in the  preparation  of the Company's  2001 Annual
Report on 10-KSB.

Certain information and footnote  disclosures normally included in the financial
statements presented in accordance with generally accepted accounting principles
have been condensed or omitted. It is suggested that the accompanying  unaudited
interim  financial   statements  be  read  in  conjunction  with  the  financial
statements  and notes thereto  incorporated  by reference in the Company's  2001
Annual Report on 10-KSB.

Note 2  - Financial Results and Liquidity

To date, we have not been profitable.  We face all the risks common to companies
in  their  early  stages  of  development,   including  undercapitalization  and
uncertainty of funding sources,  high initial  expenditure  levels and uncertain
revenue  streams,  an unproven  business  model,  and  difficulties  in managing
growth.  Our  recurring  losses  raise  substantial  doubt  about our ability to
continue  as a going  concern.  Our  financial  statements  do not  reflect  any
adjustments that might result from the outcome of this uncertainty.  The Company
expects to incur losses as it expands its businesses and will require additional
funding during 2002. The  satisfaction of our cash  requirements  hereafter will
depend in large part on our ability to successfully  raise capital from external
sources to pay for our planned  expenditures and to fund  operations.  We do not
expect that sufficient cash will be generated from operations to fund our growth
for the  foreseeable  future.  As a result,  we expect  to  aggressively  pursue
additional  sources  of  funds,  the  form of which  will  vary  depending  upon
prevailing market and other conditions and may include a sale transaction or the
issuance of equity securities.

The Company has  explored  the  possibility  of selling or merging  with another
Company.  Although  the Company has not entered  into any binding  agreement  to
effect such a  transaction,  the board of directors of the Company does consider
such offers and would consider all of the terms of any such offer as part of its
fiduciary duty to determine whether any such transaction is in the best interest
of the Company's  stockholders.  If our board of directors does determine that a
sale  or  merger  of the  Company  is in the  best  interests  of the  Company's
stockholders,  our board of directors may determine to pursue such a transaction
and the  consideration to be paid in connection with such  transaction  would be
used to expand our business  and fund future  operations.  We cannot  assure you
that we will be able to raise funds through a sale or equity transaction,  or if
such funding is available,  that it will be on favorable terms. Our common stock
is currently traded on the  over-the-counter  market on the electronic  bulletin
board.

<PAGE>

Note 3 - Basic Loss Per Share

Basic  earnings  or loss per share is based on the  weighted  average  number of
shares  outstanding  during  the  period of the  financial  statements.  Diluted
earnings or loss per share are based on the  weighted  average  number of common
shares outstanding and dilutive common stock equivalents.  All per share and per
share information are adjusted retroactively to reflect stock splits and changes
in par value,  when  applicable.  All earnings or loss per share  amounts in the
financial  statements are basic earnings or loss per share.  The  computation of
basic loss per share is as follows at March 31: 2002 2001

<TABLE>
<CAPTION>
<S>                                                                                     <C>               <C>
Numerator-net loss available to common stockholders                                     $     (44,390)    $   (273,169)

Denominator-weighted average number of common shares outstanding                          123,466,166       13,364,566

Basic and diluted loss per common share                                                 $     (0.0003)    $      (0.02)

</TABLE>

<PAGE>

Item 2. Management's  Discussion and Analysis of Financial Condition and Results
        of Operations

When used in this discussion, the words "believes", "anticipates", "expects" and
similar expressions are intended to identify  forward-looking  statements.  Such
statements  are subject to certain  risks and  uncertainties,  which could cause
actual results to differ materially from those projected.  Readers are cautioned
not to place undue  reliance on these  forward-looking  statements,  which speak
only as of the date hereof.  The Company  undertakes  no obligation to republish
revised forward-looking  statements to reflect events or circumstances after the
date hereof or to reflect the occurrence of  unanticipated  events.  Readers are
also urged to carefully review and consider the various  disclosures made by the
Company which attempt to advise  interested  parties of the factors which affect
the  Company's  business,  in this  report,  as well as the  Company's  periodic
reports on Forms 10-KSB,  10-QSB and 8-K filed with the  Securities and Exchange
Commission.

Overview
--------

Enterprise  Technologies,  Inc.  is the  developer  of the  MedCare  Program,  a
non-pharmaceutical,  non-invasive  treatment program for patients suffering from
urinary incontinence and other pelvic disorders,  including pelvic pain, chronic
constipation, fecal incontinence and disordered defecation.

Due to the lack of significant  revenues and high operating cost associated with
supporting its various  physician  office and hospital based program sites,  the
Company  has  suffered  large  operating  losses.  In order to reduce  operating
expenses, the Company terminated all of its MedCare Program sites in March 2001.
The Company is currently  searching  for potential  joint venture  partners that
have  existing  operating  infrastructures  to which the MedCare  Program can be
added as an ancillary  service with minimal overhead.  Additionally,  Enterprise
plans to develop other  potential  revenue  streams from the  Company's  current
intellectual property base and other technology based ventures.

Results of Operations
---------------------

Revenues.  The Company  generated  $0 for the month period ended March 31, 2002,
versus  $24,560 in revenues  for the three  months  ended March 31,  2001.  This
decrease in revenues is due to the termination of the Company's  MedCare Program
sites. To date, the Company has not relied on revenues for funding.

General and  Administrative  Expenses.  During the three  months ended March 31,
2002, the Company incurred $44,403 in general and administrative expenses versus
$284,978,  a decrease  of 84% from the same  period in 2001.  This  decrease  is
primarily due to lower operating  expenses and reflects a significant  reduction
in the ongoing costs of maintaining the Company's operations.

Interest  Income.  Interest income was $13 and $1,115 for the three months ended
March 31,  2002  compared  to the same  period in 2001.  Interest  earned in the
future will be  dependent  on Company  funding  cycles and  prevailing  interest
rates.  Provision  for  Income  Taxes.  As of  March  31,  2002,  the  Company's
accumulated  deficit  was  $13,942,515,  and as a  result,  there  has  been  no
provision for income taxes.

<PAGE>

Net Loss. For the three-month  period ended March 31, 2002 and 2001, the Company
recorded a net loss of $44,390 or $0.0003 per share,  and  $273,169 or $0.02 per
share, respectively.  This decrease is primarily due to lower operating expenses
and reflects a  significant  reduction in the ongoing costs of  maintaining  the
Company's operations.

Liquidity and Capital Resources
-------------------------------

At March 31, 2002, the Company had a cash balance of $7,824,  compared to $6,760
at December 31, 2001. The Company has financed its operations  primarily through
cash on hand during the three month  period ended March 31, 2002 and from a loan
of $10,200  from Harmel S. Rayat,  a director and  majority  shareholder  of the
Company.  The  Company  cannot  pay its  current  liabilities  and will  require
additional funds.

Net cash  flows used by  operating  activities  was  $9,136 for the three  month
period  ending  March 31,  2002,  compared  to net cash flows used by  operating
activities  of $126,468 for the same period in 2001.  This change was  primarily
due to a decrease  in net losses for the  three-month  period  ending  March 31,
2002.

Net cash flows provided by financing  activities was $10,200 for the three-month
period ending March 31, 2002,  compared to $188,671 for the same period in 2001,
representing  loans from shareholder and proceeds from the sale of common stock,
respectively.

Plan of Operation
-----------------

For the next  twelve  months,  the  Company  plans  to  continue  searching  for
potential joint venture partners that have existing operating infrastructures to
which the MedCare  Program can be added as an  ancillary  service  with  minimal
overhead.   Additionally,  the  Company  plans  to  develop  additional  revenue
potential  streams from the  Company's  current  intellectual  property base and
other technology based ventures, which the Company's management team is actively
evaluating.

The Company  does not expect to purchase  any  significant  equipment,  hire any
additional employees, or incur research and development expenses.

In order to satisfy  its cash needs over the next  twelve  months,  the  Company
plans  to fund its  operations  from  cash in the  bank and also  plans to raise
additional   financing  from  third  parties.   The  Company's   future  funding
requirements  will  depend  on  numerous  factors.  These  factors  include  the
Company's  ability to find  suitable  joint  venture  partners  for its  MedCare
Program,  operate  its  business  profitably  in the  future,  recruit and train
qualified management,  technical and sales personnel,  and the Company's ability
to compete against other, better capitalized corporations.

The  Company  may raise  additional  funds  through  private  or  public  equity
investments  in order to expand the range and scope of its business  operations.
In doing so, the Company may seek  access to the private or public  equity,  but
there is no  assurance  that such  additional  funds will be  available  for the
Company to finance its operations on acceptable terms, if at all.

<PAGE>

Related Party Transactions
--------------------------

During the three month period ended March 31, 2002, the Company  charged $36,000
to operations for management and consulting fees incurred for services  rendered
by Harmel S. Rayat, a director and majority shareholder of the Company. Included
in accounts payable at March 31, 2002, is a payable of $36,000 for these fees.

The Company's  office is located at Suite 216, 1628 West 1st Avenue,  Vancouver,
BC,  V6J 1G1.  These  premises  are owned the wife and  father of the  Company's
Director and Chairman.  At present,  the Company pays no rent. The fair value of
the rent has not been included in the financial statements because the amount is
immaterial

<PAGE>

PART II -- OTHER INFORMATION

Item 1.  Legal Proceedings
--------------------------

None

Item 2.  Changes in Securities
------------------------------

None

Item 3.  Defaults Upon Senior Securities
----------------------------------------

None

Item 4.  Submission of Matters to a Vote of Security Holders
------------------------------------------------------------

None

Item 5.  Other Information
--------------------------

None

Item 6.  Exhibits and Reports on Form 8-K
-----------------------------------------

On January  22,  2002,  the  Company  filed a Form 8-K with the  Securities  and
Exchange  Commission  announcing  that  the  Company's  Board of  Directors  had
authorized the issuance of 94,401,600  restricted shares of the Company's Common
Stock for the  conversion  of 81.5 Series B Preferred  shares and an  additional
13,700,000  restricted shares of Common Stock for debts and management fees owed
as of December 31, 2001 to Harmel S. Rayat, a Director and majority  shareholder
of the Company.

On January 28, 2002,  the Company  filed a Form 8-K as a  supplement  to the 8-K
filed on January 22, 2002, which  erroneously  listed Harv Dhaliwal as President
and Director of the Company. Mr. Dhaliwal is Treasurer,  Secretary, and Director
of Enterprise Technologies, Inc.


                                 Signature Page

     Pursuant  to the  requirements  of  section  13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.


                                                   ENTERPRISE TECHNOLOGIES, INC.

                                                                  /s/ Ray Krauss
                                                                  --------------
                                                                      Ray Krauss
                                                               CEO and President

                                                             /s/ Harmel S. Rayat
                                                             -------------------
                                                                 Harmel S. Rayat
                                                           Director and Chairman

                                                          /s/ Harvinder Dhaliwal
                                                          ----------------------
                                                              Harvinder Dhaliwal
                                               Director, Secretary and Treasurer

Dated:  May 6, 2002